Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Evgeny V. Gluhanyuk"'
Autor:
Pavel I Makarevich, Konstantin V Dergilev, Zoya I Tsokolaeva, Maria A Boldyreva, Evgeniy K Shevchenko, Evgeny V Gluhanyuk, Julia O Gallinger, Mikhail Yu Menshikov, Yelena V Parfyonova
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0197566 (2018)
Since development of plasmid gene therapy for therapeutic angiogenesis by J. Isner this approach was an attractive option for ischemic diseases affecting large cohorts of patients. However, first placebo-controlled clinical trials showed its limited
Externí odkaz:
https://doaj.org/article/d3a1beebf10540bcbcd5ec1e9aa769f2
Autor:
Elena Zerkalenkova, Svetlana Kashpor, Natalia Miakova, Michael Maschan, Galina Novichkova, Ekaterina Mikhailova, Alexey Maschan, Olga Illarionova, Larisa Shelikhova, Yulia Diakonova, Yulia Olshanskaya, Alexander Popov, Evgeny V. Gluhanyuk
Publikováno v:
Haematologica
Not available.
Autor:
Alexander Popov, Alexey Kazachenok, Dmitriy Pershin, Alexey Maschan, Daria Shasheleva, Rimma Khismatullina, Larisa Shelikhova, Elena Kurnikova, Evgeny V. Gluhanyuk, Yakov Muzalevsky, Galina Novichkova, Svetlana Kashpor, Irina Kalinina, Dmitriy Balashov, Michael Maschan
Publikováno v:
Blood. 134:150-150
Introduction The outcome HSCT in a cohort of children with chemorefractory acute leukemia (AL) is poor. The incidence of relapse exceeds 50% and survival varies from 10 to 40%. Additional attempts at remission induction with various combinations of c
Autor:
Evgeniy K. Shevchenko, Pavel I. Makarevich, Yelena V. Parfyonova, Mikhail Menshikov, Z. I. Tsokolaeva, K. V. Dergilev, Evgeny V. Gluhanyuk, M. Boldyreva, Julia O. Gallinger
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 5, p e0197566 (2018)
PLoS ONE, Vol 13, Iss 5, p e0197566 (2018)
Since development of plasmid gene therapy for therapeutic angiogenesis by J. Isner this approach was an attractive option for ischemic diseases affecting large cohorts of patients. However, first placebo-controlled clinical trials showed its limited
Autor:
Evgeny V. Gluhanyuk, K. V. Dergilev, Yelena V. Parfyonova, Anastasia Efimenko, Pavel I. Makarevich, Yu-Chen Hu, M. Boldyreva, Julia O. Gallinger
Publikováno v:
Molecular Therapy. 24:S178
Engineering of cell sheets (CS) is an effective approach for delivery of cells to induce angiogenesis and tissue regeneration. Basis for increased CS efficacy is better engraftment and cell survival due to absence of anoikis and intact cell-to-cell i
Autor:
Pavel I. Makarevich, K. V. Dergilev, Yu-Chen Hu, Anastasia Efimenko, Evgeny V. Gluhanyuk, Stepan S. Sarkisyan, E.K. Shevchenko, M. Boldyreva, Julia O. Gallinger, Polina A. Rodina, Yelena V. Parfyonova, G. V. Sharonov
Publikováno v:
Stem Cell Research & Therapy
Introduction Cell therapy using adipose-derived stromal cells (ADSC) is an intensively developing approach to promote angiogenesis and regeneration. Administration technique is crucial and among others minimal constructs - cell sheets (CS) have certa